Foscarbidopa + Foslevodopa
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Foscarbidopa
foscarbidopa - Foslevodopa
foslevodopa
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| VyalevAUCAUS | 12 mg / 240 mg / 2,400 mg / 120 mg | ABBVIE CORPORATION |
| foscarbidopa/foslevodopaAUUS | 12 mg / 240 mg | AbbVie Inc. |
| foslevodopa + foscarbidopaAUES | 240 mg / 12 mg / 2,400 mg / 120 mg | AbbVie Pty Ltd |
| Produodopa 2.4g/10ml / 120mg/10ml solution for infusion vialsGB | 2,400 mg / 120 mg | AbbVie Ltd |
| Foslevodopa 2.4g/10ml / Foscarbidopa 120mg/10ml solution for infusion vialsGB | 2,400 mg / 120 mg | AbbVie Ltd |
| VYALEV foslevodopa 2400 mg/10 mL and foscarbidopa 120 mg/10 mL solution for subcutaneous infusion vialAU | 2,400 mg / 120 mg | Abbvie Pty Ltd |
Same combination in other markets
These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.
- CA · VYALEV · 1 products · record
- ES · DUODOPA · 1 products · record
- GB · Produodopa 2.4g/10ml / 120mg/10ml solution for infusion vials · 1 products · record
- US · VYALEV · 1 products · record
- AU · VYALEV · 1 products · record
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.